Page last updated: 2024-10-23

azathioprine and Allergic Bronchopulmonary Mycosis

azathioprine has been researched along with Allergic Bronchopulmonary Mycosis in 2 studies

Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lazarescu, RE1
Vinelli, M1
Jung, HY1
Choe, JY1
Park, SH1
Kim, SK1

Other Studies

2 other studies available for azathioprine and Allergic Bronchopulmonary Mycosis

ArticleYear
Dissemination of invasive aspergillosis: diagnostic and management dilemmas.
    BMJ case reports, 2014, Sep-04, Volume: 2014

    Topics: Autopsy; Azathioprine; Diagnosis, Differential; Fatal Outcome; Female; Hepatitis, Autoimmune; Humans

2014
Invasive aspergillosis related with azathioprine-induced leucopenia without mutant allele of thioprine methyltransferase in a patient with rheumatoid arthritis.
    Rheumatology international, 2011, Volume: 31, Issue:5

    Topics: Aged; Amphotericin B; Antifungal Agents; Antirheumatic Agents; Arthritis, Rheumatoid; Azathioprine;

2011